An emerging probiotic with liver health benefits for smokers

Wei Jia; Xiaojiao Zheng

doi:10.1093/lifemeta/loac033

An emerging probiotic with liver health benefits for smokers

Wei Jia^*, Xiaojiao Zheng

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

1 Citation (Scopus)

Abstract

Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

Original language	English
Article number	loac033
Number of pages	2
Journal	Life Metabolism
Volume	2
Issue number	1
DOIs	https://doi.org/10.1093/lifemeta/loac033
Publication status	Published - Feb 2023

Scopus Subject Areas

Biochemistry, Genetics and Molecular Biology (miscellaneous)
Cell Biology
Biochemistry, medical
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/lifemeta/loac033

Cite this

@article{07afe90807674d0399278e4397a490d8,

title = "An emerging probiotic with liver health benefits for smokers",

abstract = "Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.",

author = "Wei Jia and Xiaojiao Zheng",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2023",

month = feb,

doi = "10.1093/lifemeta/loac033",

language = "English",

volume = "2",

journal = "Life Metabolism",

issn = "2097-2555",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - An emerging probiotic with liver health benefits for smokers

AU - Jia, Wei

AU - Zheng, Xiaojiao

PY - 2023/2

Y1 - 2023/2

N2 - Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

AB - Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

UR - http://www.scopus.com/inward/record.url?scp=85162755762&partnerID=8YFLogxK

U2 - 10.1093/lifemeta/loac033

DO - 10.1093/lifemeta/loac033

M3 - Journal article

AN - SCOPUS:85162755762

SN - 2097-2555

VL - 2

JO - Life Metabolism

JF - Life Metabolism

IS - 1

M1 - loac033

ER -

An emerging probiotic with liver health benefits for smokers

Abstract

Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this